Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
69
datasets available to search
ShareScore release 0.9.0
Dataset results
69 results for “plasma proteome”
Targeted proteomics analysis of Cutaneous Lupus Erythematosus patient interstitial skin fluid and plasma (Inflammation panel data)
GEO Series GSE182301. Homo sapiens. 38 samples. Type: Other.
Targeted proteomics analysis of Cutaneous Lupus Erythematosus patient interstitial skin fluid and plasma (Neuro Exploratory panel data)
GEO Series GSE182300. Homo sapiens. 38 samples. Type: Other.
APOE genotype or brain amyloid alters the plasma proteome in elderly subjects without dementia
GEO Series GSE275392. Homo sapiens. 53 samples. Type: Protein profiling by protein array.
Lung cancer signatures in plasma based on proteome profiling of mouse tumor models
GEO Series GSE28480. Homo sapiens. 8 samples. Type: Expression profiling by array.
Transcriptomics and proteomics approach for the identification of altered blood microRNAs and plasma proteins in Parkinson’s disease by Custom Brain Specific miRNA OpenArray Real-time PCR panel
GEO Series GSE222480. Homo sapiens. 96 samples. Type: Expression profiling by RT-PCR.
Age prediction from human blood plasma using proteomic and small RNA data: a comparative analysis
GEO Series GSE182598. Homo sapiens. 103 samples. Type: Non-coding RNA profiling by high throughput sequencing.
Definition of human cardiac progenitor cell plasma membrane signature: comparative genomic and proteomics analysis with human mesenchymal stem cells
GEO Series GSE84070. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
Plasma and CSF Proteomic Signatures of Acutely Sleep-Deprived Humans: An Exploratory Study
GEO Series GSE244817. Homo sapiens. 40 samples. Type: Protein profiling by protein array.
Data from: Assessment of plasma proteomics biomarker's ability to distinguish benign from malignant lung nodules
Background: Lung nodules are a diagnostic challenge, with an estimated yearly incidence of 1.6 million in the United States. This study evaluated the accuracy of an integrated proteomic classifier in identifying benign nodules in patients with a pretest probability of cancer (pCA) ≤ 50%. Methods: A prospective, multicenter observational trial of 685 patients with 8- to 30-mm lung nodules was conducted. Multiple reaction monitoring mass spectrometry was used to measure the relative abundance of two plasma proteins, LG3BP and C163A. Results were integrated with a clinical risk prediction model to identify likely benign nodules. Sensitivity, specificity, and negative predictive value were calculated. Estimates of potential changes in invasive testing had the integrated classifier results been available and acted on were made. Results: A subgroup of 178 patients with a clinician-assessed pCA ≤ 50% had a 16% prevalence of lung cancer. The integrated classifier demonstrated a sensitivity of 97% (CI, 82-100), a specificity of 44% (CI, 36-52), and a negative predictive value of 98% (CI, 92-100) in distinguishing benign from malignant nodules. The classifier performed better than PET, validated lung nodule risk models, and physician cancer probability estimates (P < .001). If the integrated classifier results were used to direct care, 40% fewer procedures would be performed on benign nodules, and 3% of malignant nodules would be misclassified. Conclusions: When used in patients with lung nodules with a pCA ≤ 50%, the integrated classifier accurately identifies benign lung nodules with good performance characteristics. If used in clinical practice, invasive procedures could be reduced by diverting benign nodules to surveillance. Trial Registry: ClinicalTrials.gov; No.: NCT01752114; URL: www.clinicaltrials.gov).
Peripheral Plasma Micro-RNA and Proteomics Mapping in Depressive Patients, Treated With SSRI Medications
ClinicalTrials.gov study NCT01681407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
ClinicalTrials.gov study NCT05742204. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Alterations in the Plasma Proteome of Early-Onset Severe Preeclampsia
ClinicalTrials.gov study NCT00719654. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Characterization of the Plasma Proteome Following Left Ventricular Assist Device Implantation
ClinicalTrials.gov study NCT02428894. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology
ClinicalTrials.gov study NCT06865898. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effects of Trout Fed With a Vegetable Based Feed on Cardiovascular Risk Markers and Plasma Proteome
ClinicalTrials.gov study NCT00445614. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Data from: Assessment of plasma proteomics biomarker’s ability to distinguish benign from malignant lung nodules
Open the record for dataset details and reuse information.
Plasma proteomics and organ dysfunction in COVID-19 ARDS
GEO Series GSE283501. Homo sapiens. 66 samples. Type: Protein profiling by protein array.
Plasma proteomics in preterm birth and normal pregnancy
GEO Series GSE150167. Homo sapiens. 210 samples. Type: Protein profiling by protein array.
Human Plasma Proteome During Normal Pregnancy
GEO Series GSE206454. Homo sapiens. 519 samples. Type: Protein profiling by protein array.
Targeted proteomics analysis of Cutaneous Lupus Erythematosus patient interstitial skin fluid and plasma
GEO Series GSE182302. Homo sapiens. 76 samples. Type: Other.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.